- What is IdentifAI Genetics' primary focus?
- IdentifAI Genetics is developing a noninvasive prenatal test for the early detection of single-gene disorders using a first-trimester maternal blood test.
- When was IdentifAI Genetics founded?
- IdentifAI Genetics was founded in November 2020.
- What is the current employee count for IdentifAI Genetics?
- IdentifAI Genetics has 11-50 employees.
- What is the total amount of funding IdentifAI Genetics has raised to date?
- IdentifAI Genetics has raised a total of $10,250,000.
- Which investor participated in IdentifAI Genetics' Pre-Seed round in January 2021?
- Shizim Group was a lead investor in IdentifAI Genetics' Pre-Seed round in January 2021.
- Which entity provided a grant to IdentifAI Genetics in February 2023?
- The Israel Innovation Authority provided a $2,500,000 grant to IdentifAI Genetics in February 2023.
- Who led IdentifAI Genetics' Seed funding round in April 2023?
- eHealth Ventures led IdentifAI Genetics' Seed funding round in April 2023.
- What is the most recent grant IdentifAI Genetics received, and from whom?
- IdentifAI Genetics received a $1,000,000 grant from the BIRD Foundation in May 2026.
- Who are the co-founders of IdentifAI Genetics?
- The co-founders of IdentifAI Genetics are Yossi Bornstein, Noam Shomron, and Oren Tadmor.
- What is the core technology developed by IdentifAI Genetics?
- IdentifAI Genetics' core technology is the Hoobari paradigm, a patent-pending methodology developed at Tel Aviv University, used for comprehensive genetic analysis.